Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

October 2, 2023

Genentech to Present New Key Clinical and Real-world Data at ECTRIMS-ACTRIMS 2023 Showcasing Strength of Long-term Outcomes in MS and NMOSD

  • MS Drug Therapies
    /
  • NMO (NMOSD/Devics)
    /
 Late-breaking results from Phase III trial of Ocrevus (ocrelizumab) subcutaneous injection and Phase II trial of BTK inhibitor fenebrutinib in…
MS Drug Therapies

October 2, 2023

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

  • NMO (NMOSD/Devics)
    /
  Abstract Objective:  To evaluate clinical features among patients with neuromyelitis optica spectrum disorders (NMOSD) who have myelin oligodendrocyte glycoprotein…
NMO (NMOSD/Devics)

October 1, 2023

DEMENTIA – an overview, causes and symptoms

  • Neurologic Illnesses
    /
  • Syndromes & etc
    /
Overview Dementia is a term used to describe a group of symptoms affecting memory, thinking and social abilities. In people…
Neurologic Illnesses

September 29, 2023

Reframing MS — A new Patient resource with Jamie-Lynn Sigler (Sopranos)

  • Additional MS resource sites
    /
  • An MS Patients Story
    /
 Novartis is collaborating with mom, actor, MS advocate, and KESIMPTA patient Jamie-Lynn Sigler to share what she has learned in…
Additional MS resource sites

September 28, 2023

Barriers in MS Treatment Adherence

  • Additional MS resource sites
    /
  • MS BIOMARKERS
    /
  2023 , Octave Although there currently is no cure for multiple sclerosis, in recent decades, 20+ disease-modifying therapies (DMTs)…
Additional MS resource sites

September 22, 2023

Generic and Biosimilar Medications for MS

  • MS Drug Therapies
    /
  • MS Specialty Pharmacy
    /
  • National MS Society Related
    /
 Generics and biosimilars are follow-on medications. A generic is a follow-on medication to a brand medication and a biosimilar is…
MS Drug Therapies

September 21, 2023

Introducing: FOOT DROP FOUNDATIONS ‘ – Brain Based Exercise to Counteract Your Foot Drop Symptoms’

  • Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)
    /
 Press the Play Button to Watch the brief Video Below and Learn How Foot Drop Foundations   Will Get You on the RIGHT Path to Counteract…
Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)

September 21, 2023

What does the Inflation Reduction Act mean for you?

  • Access to Care
    /
  • Health Equity
    /
  • National MS Society Related
    /
 September 12, 2023 Last year, President Biden signed the Inflation Reduction Act into law. Many changes are going to occur…
Access to Care

September 20, 2023

What actually is, the Neurofilament light chain for MS?

  • MS Research Study and Reports
    /
 Blood levels of sNfL, a neuron-specific cytoskeletal protein, have emerged as a biomarker able to capture neuronal damage in multiple sclerosis…
MS Research Study and Reports

September 20, 2023

Blood levels of neurofilament light are associated with disease progression in a mouse model of spinocerebellar ataxia type 3

  • MS Research Study and Reports
    /
 Abstract Increased neurofilament light (NfL; NEFL) protein in biofluids is reflective of neurodegeneration and has gained interest as a biomarker…
MS Research Study and Reports

Categories

Latest Blog Posts